生物标志物 生物标志物
Dana N Broberg1,2, Sandra E Black3,4, Richard H Swartz3,4
1Robarts Research Institute, London, ON, Canada.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
帕金森病患者比阿尔茨海默病/轻度认知障碍和脑血管疾病患者表现出更好的白质完整性. 先进的扩散成像可能会揭示帕金森病中微妙的白质变化.
科学领域:
- 神经成像是一种神经成像.
- 神经学 神经学
- 生物标志物 生物标志物
背景情况:
- 扩散张力成像 (DTI) 是评估神经退行性疾病中白质完整性的有价值生物标志物.
- 以前的研究已经在阿尔茨海默病/轻度认知障碍 (ADMCI),帕金森病 (PD) 和脑血管疾病 (CVD) 中探索了DTI,但这些病因之间的白质微观结构的直接比较是有限的.
研究的目的:
- 在患有ADMCI,PD和CVD的患者中描述和比较白质管道微观结构.
- 研究DTI指标作为区分这些神经退行性疾病的生物标志物的实用性.
主要方法:
- 利用了来自安大略省神经退行性疾病研究倡议 (ONDRI) 队列的DTI和T1MRI数据.
- 使用FreeSurfer的TRACULA重建了39条白质路径,并计算了DTI指标 (FA,MD,AxD,RD).
- 采用多变量通用线性模型来评估诊断对DTI指标的影响.
主要成果:
- 诊断显著影响了整个白质通道的所有四个DTI指标 (FA,MD,AxD,RD).
- 与ADMCI和CVD患者相比,帕金森病 (PD) 患者表现出较高的分数异构 (FA) 和较低的平均扩散率 (MD),轴向扩散率 (AxD) 和辐射扩散率 (RD).
- 在白质微观结构中,在ADMCI和CVD参与者之间观察到最小的显著差异.
结论:
- 与ADMCI和CVD患者相比,帕金森病患者表现出更多的白质微结构完整性.
- 较低的FA值和较高的RD和MD值表明ADMCI和CVD中的白质完整性受到损害.
- 可能需要先进的扩散成像技术来检测PD中微妙的白质微观结构变化.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511